Incretin Atlas·MoleculesTrialsOutcomesTimelinePipelineAboutMedical Adviser's Group
Incretin Atlas › Trials › LIGHTEN (HS-20094-301)

LIGHTEN (HS-20094-301)

HS-20094 · obesity

Data cut 12 November 2026 · page built 16 November 2026

Design

Molecule(s)
HS-20094
Population
obesity
Phase
3
Participants
604
Duration
48 weeks

Results by arm

ArmPopulationWeeksnWeight, efficacyWeight, treatment-policyHbA1c, ppAE discontinuation, %Any discontinuation, %Nausea, %Vomiting, %SAE, %SBP, mmHgStatus
5 mgobesity china48604−12.5 % vs −2.7 %
Δ −9.8 pp
−11.8 % vs −2.5 %
Δ −9.3 pp
———————congress
10 mgobesity china48604−17.5 % vs −2.7 %
Δ −14.8 pp
−17.0 % vs −2.5 %
Δ −14.5 pp
———————congress
15 mgobesity china48604−19.3 % vs −2.7 %
Δ −16.6 pp
−18.7 % vs −2.5 %
Δ −16.2 pp
———————congress

Weight: percent change from baseline, drug vs placebo or comparator, Δ = difference in percentage points. Efficacy estimand = effect while on treatment (hypothetical strategy); treatment-policy = all randomised participants regardless of adherence (ITT). AE discontinuation = stopped study drug for any adverse event. Hover a status for its definition.

Notes

Verbatim quotes from the source (6)
  • 5 mg · weight_tp · EQS release
    Under the treatment-regimen estimand, mean body weight reductions were
  • 5 mg · weight_eff · EQS release
    under the efficacy estimand, mean body weight reductions at week 48
  • 10 mg · weight_tp · EQS release
    Under the treatment-regimen estimand, mean body weight reductions were
  • 10 mg · weight_eff · EQS release
    under the efficacy estimand, mean body weight reductions at week 48
  • 15 mg · weight_tp · EQS release
    Under the treatment-regimen estimand, mean body weight reductions were
  • 15 mg · weight_eff · EQS release
    under the efficacy estimand, mean body weight reductions at week 48

Primary sources

How to cite this page

Medical Adviser's Group. Incretin Atlas: LIGHTEN (HS-20094-301). Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/trials/lighten/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.

Cite the primary publication for any single result; every value above links to it.